loadpatents
name:-0.028163909912109
name:-0.016459941864014
name:-0.0056250095367432
Kroemer; Guido Patent Filings

Kroemer; Guido

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kroemer; Guido.The latest application filed is for "use of caloric restriction mimetics for potentiating chemo-immunotherapy for the treatment of cancers".

Company Profile
5.15.30
  • Kroemer; Guido - Paris FR
  • KROEMER; Guido - Paris cedex 06 FR
  • Kroemer; Guido - Milan IT
  • Kroemer; Guido - Villejuif FR
  • KROEMER; Guido - Milano IT
  • Kroemer; Guido - Antony FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof
Grant 11,040,052 - Kroemer , et al. June 22, 2
2021-06-22
Simultaneous detection of cannibalism and senescence as prognostic marker for cancer
Grant 10,969,380 - Perfettini , et al. April 6, 2
2021-04-06
Use Of Caloric Restriction Mimetics For Potentiating Chemo-immunotherapy For The Treatment Of Cancers
App 20210030703 - KROEMER; Guido ;   et al.
2021-02-04
Use Of Triethylenetetramine (teta) For The Therapeutic Induction Of Autophagy
App 20200360305 - KROEMER; Guido ;   et al.
2020-11-19
Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages
App 20200297749 - PERFETTINI; Jean-Luc ;   et al.
2020-09-24
Methods And Pharmaceutical Compositions For Modulating Autophagy
App 20200268837 - KROEMER; Guido ;   et al.
2020-08-27
Methods And Pharmaceutical Compositions For Modulating Autophagy In A Subject In Need Thereof
App 20190008884 - KROEMER; Guido ;   et al.
2019-01-10
Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages
App 20180125876 - Perfettini; Jean-Luc ;   et al.
2018-05-10
Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections
Grant 9,938,528 - Kroemer , et al. April 10, 2
2018-04-10
Simultaneous Detection Of Cannibalism And Senescence As Prognostic Marker For Cancer
App 20170363613 - PERFETTINI; JEAN-LUC ;   et al.
2017-12-21
Methods and Pharmaceutical Compositions for Treating Human Immunodeficiency Virus Type 1 (HIV-1) Infections
App 20170342411 - KROEMER; Guido ;   et al.
2017-11-30
Combined therapy for cystic fibrosis
Grant 9,730,922 - Maiuri , et al. August 15, 2
2017-08-15
Simultaneous detection of cannibalism and senescence as prognostic marker for cancer
Grant 9,726,661 - Perfettini , et al. August 8, 2
2017-08-08
Methods And Pharmaceutical Compositions For Modulating Autophagy In A Subject In Need Thereof
App 20160250249 - KROEMER; Guido ;   et al.
2016-09-01
Methods for Treating Mitochondrial Disorders and Neurodegenerative Disorders
App 20160031955 - Modjtahedi; Nazanine ;   et al.
2016-02-04
Combined Therapy For Cystic Fibrosis
App 20150328203 - MAIURI; Luigi ;   et al.
2015-11-19
Combined therapy for cystic fibrosis
Grant 9,132,123 - Maiuri , et al. September 15, 2
2015-09-15
Simultaneous Detection Of Cannibalism And Senescence As Prognostic Marker For Cancer
App 20150185202 - Perfettini; Jean-Luc ;   et al.
2015-07-02
Method of treatment for immunogenic treatment resistant cancer
Grant 8,865,653 - Zitvogel , et al. October 21, 2
2014-10-21
Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
Grant 8,828,944 - Zitvogel , et al. September 9, 2
2014-09-09
Combined Therapy For Cystic Fibrosis
App 20130310329 - Maiuri; Luigi ;   et al.
2013-11-21
Prognostic And/or Predictive Biomarkers And Biological Applications Thereof
App 20130281313 - Galluzzi; Lorenzo ;   et al.
2013-10-24
Toll like receptor 4 dysfunction and the biological applications thereof
Grant 8,557,517 - Apetoh , et al. October 15, 2
2013-10-15
Compounds And Uses Thereof To Induce An Immunogenic Cancer Cell Death In A Subject
App 20130156790 - ZITVOGEL; LAURENCE ;   et al.
2013-06-20
Methods And Pharmaceutical Compositions For The Treatment Of Hiv-1 Infections
App 20130156791 - Perfettini; Jean-luc ;   et al.
2013-06-20
Compounds And Uses Thereof To Induce An Immunogenic Cancer Cell Death In A Subject
App 20130052160 - Zitvogel; Laurence ;   et al.
2013-02-28
Compounds regulating calreticulin, KDEL receptor and/or Erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment
Grant 8,263,344 - Kroemer , et al. September 11, 2
2012-09-11
Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereof
Grant 8,129,340 - Kroemer , et al. March 6, 2
2012-03-06
Use Of P2x7 Pathway For Assessing The Sensitivity Of A Subject To A Cancer Treatment
App 20110229411 - Apetoh; Lionel ;   et al.
2011-09-22
Therapeutic Combination Of A Panher/vegfr2 Kinase Inhibitor And A Platinum Compound
App 20100136137 - Wong; Tai W. ;   et al.
2010-06-03
Compounds Regulating Calreticulin, KDEL Receptor and/or ERP-57 Cell Surface Exposure and Uses Thereof to Evaluate the Efficiency of a Cancer Treatment
App 20100015653 - Kroemer; Guido ;   et al.
2010-01-21
Inhibitors of Protein Phosphatase 1, GADD34 and Protein Phosphatase 1/GADD34 Complex, Preparation and Uses Thereof
App 20100016235 - Kroemer; Guido ;   et al.
2010-01-21
Toll Like Receptor 4 Dysfunction and the Biological Applications Thereof
App 20100004161 - Apetoh; Lionel ;   et al.
2010-01-07
Screening methods for the identification of inhibitors of human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT)
Grant 7,642,051 - Jacotot , et al. January 5, 2
2010-01-05
Cancer Treatment Resistance and Agents Modulating Such Resistance
App 20080299101 - Gourdier; Isabelle ;   et al.
2008-12-04
Mimetics and inhibitors of the interaction between Vpr (HIV viral protein of regulation) and ANT (Mitochondrial adenine nucleotide translocator)
Grant 7,056,735 - Jacotot , et al. June 6, 2
2006-06-06
Mechanism of mitochondrial membrane permeabilization by HIV-1 VPR, mimetics of Vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of Vpr with ANT
App 20060052285 - Jacotot; Etienne Daniel Francois ;   et al.
2006-03-09
Mechanism of mitochondrial membrane permeabilization by HIV-1 Vpr, mimetics of Vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of Vpr with ANT
App 20040072146 - Jacotot, Etienne Daniel Francois ;   et al.
2004-04-15
Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agent
App 20030166598 - Decaudin, Didier ;   et al.
2003-09-04
Mimetics and inhibitors of the interaction between Vpr (HIV vIral protein of regulation) and ANT(mitochondrial adenine nucleotide translocator)
App 20020068273 - Jacotot, Etienne Daniel Francois ;   et al.
2002-06-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed